Neil Stahl - Feb 7, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Neil E. Stahl
Stock symbol
REGN
Transactions as of
Feb 7, 2024
Transactions value $
-$7,637,954
Form type
4
Date filed
2/8/2024, 04:02 PM
Previous filing
Feb 6, 2024
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$94.7K -100 -0.17% $947.34 60K Feb 7, 2024 Direct
transaction REGN Common Stock Sale -$1.8M -1.89K -3.16% $948.69 58.1K Feb 7, 2024 Direct F1
transaction REGN Common Stock Sale -$571K -601 -1.04% $949.45 57.5K Feb 7, 2024 Direct F2
transaction REGN Common Stock Sale -$2.97M -3.13K -5.44% $950.43 54.3K Feb 7, 2024 Direct F3
transaction REGN Common Stock Sale -$1.18M -1.24K -2.28% $951.49 53.1K Feb 7, 2024 Direct F4
transaction REGN Common Stock Sale -$1.01M -1.06K -1.99% $952.49 52K Feb 7, 2024 Direct F5
transaction REGN Common Stock Sale -$18.1K -19 -0.04% $953.00 52K Feb 7, 2024 Direct
holding REGN Common Stock 5.83K Feb 7, 2024 By 401(k) Plan
holding REGN Common Stock 4.61K Feb 7, 2024 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,894 shares of Company stock on February 7, 2024 at prices ranging from $948.19 to $948.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F2 Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 1,237 shares of Company stock on February 7, 2024 at prices ranging from $951.00 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 1,059 shares of Company stock on February 7, 2024 at prices ranging from $952.03 to $952.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.